1Sandedrs DR, Vukieh JA. Comparison of implantable eontaet lens and la- ser assisted in situ Keratomileusis of moderate to high myopia[ J]. Come- a,2003,22(4) :324-331.
2Schwartz EJ, Molina-Kirsch H, Zhao SC, et al. characterizatlion of nasal-type extranodal NK/T-cell lymphoma using a tis- sue microarray :An analysis of 84 cases [ J]. Am J Clin Pathol,2008,130 (4) :343-351.
3Li YX, Fang H, Liu QF, et al. Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring[ J]. Blood,2008,112 (22) :3057-3064.
4Zhang YC, Zhao S. Gastric involvement of extranodal NK/T-cell lympho- ma, nasal type : A report of 3 cases with literature review [ J ]. J Surg Int Pathol,2008,16 (4) :450-454.
5Chuang SS,Chang ST, Lee YH, et al. Prostatic involvement by nasal NK/ T cell lymphoma forming lymphoepithelial lesions [ J ] J Clin Pathol,2008, 61 (5) :399-4001.
6Kim BS, Kim DW, ImSA, et al. Effective second-line chemotherapy for extranodal NKZT-cell lymphoma consisting of et aloposide, ifosfamide, met alhotrexate and prednisolone [ J ]. Ann Onc,2009,20 ( 1 ) : 121-128.
8Qian SX, Shi PF,Gao DQ, et al. Nasal-Type NK/T cell lymphoma:clini- cal features, immunophenotype and treatment outcome [ J ]. Blood, 2008, 112:5295.
9Lee J, Suh C, Kang H J, et al. Phase I study of proteasome inhibitor borte- zomib plus CHOP in patients with advanced, aggressive T-cell or NK/T- cell lymphoma[ J]. Ann Onc ,2008,19 ( 12 ) :2079-2083.
2Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues[M]. Lyon: IARC Press, 2008.
3Li YX, Wang H, Feng XL, et al. Immunophenotypic characteristics and clinical relevance of CD56 + and CD56- extranodal nasal-type natural killer/T-cell lymphoma [ J ]. Leuk Lymphoma, 2011,52 ( 3 ) :4-17.424.
4Vose J, Armitage J, Weisenburger D, et al. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes [ J ]. J Clin Oncol, 2008,26 (25) : 4124.4130.
5Kim TM, Lee SY, Jeon YK, et al. Clinieal heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group[J]. Ann Oneol, 2008,19(8) : 1477-1484.
6Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project [J]. Blood, 2009, 113 ( 17 ) : 3931- 3937.
7Kanemitsu N, Isobe Y, Masuda A, et al. Expression of Epstein- Barr virus-encoded proteins in extranodal NK/T-cell lymphoma, nasal type (ENKL) : differences in biologic and clinical behaviors of LMPl-positive and -negative ENKL [ J]. Clin Cancer Res, 2012,18(8) :2164-2172.
8Li S, Feng X, Li T,et al. Extranodal NK/T-cell lymphoma, nasal type : a report of 73 cases at MD Anderson Cancer Center[J]. Am J Surg Pathol, 2013,37 ( 1 ) : 14-23.
9Knnami N, Takamatsu Y, Fujita M, et al. Extranodal NK/T-cell lymphoma arising from soft tissue of the left forearm[J]. Rinsho Ketsueki. 2010,51 (6) :422-426.
10Zhang S, Li T, Zhang B, et al. Transcription factors engaged in deve!opment of NK cells are commonly expressed in nasal NK/T- cell lymphomas[ J ]. Hum Pathol, 2011,42 ( 9 ) : 1319-1328.
